ViaBTC Showcases Enhanced Crypto Loan Service at Blockchain Life 2025

ViaBTC, the third-largest BTC mining pool, showcased its brand vision and Collateral-pledged Loan service as a premium sponsor at Blockchain Life 2025. The company also received the “Mining Pool of the Year Award” in a vote by the event host, highlighting its popularity and reputation. https://mma.prnewswire.com/media/2809041/ViaBTC_s_booth_Blockchain_Life_2025_attracted_global_miners_crypto_enthusiasts.jpg During the two-day event, the ViaBTC team introduced its […]

Kellanova Reports 2025 Third Quarter Results

Kellanova (NYSE: K) today published its 2025 third quarter earnings results in documents posted to the company website at https://investor.kellanova.com/financials/quarterly-results/default.aspx. A Current Report on Form 8-K was filed with the U.S. Securities and Exchange Commission and is available on its website at www.sec.gov. https://mma.prnewswire.com/media/2259772/Kellanova_Logo.jpg About Kellanova Kellanova (NYSE: K) is a leader in global snacking,

Federal Signal Reports Third Quarter Results Including 17% Net Sales Growth and 24% Operating Income Improvement; Raises Full-Year Outlook

Federal Signal Corporation (NYSE:FSS) (the “Company”), a leader in environmental and safety solutions, today reported financial results for the third quarter ended September30, 2025. Third Quarter Highlights — Net sales of $555 million, up $81 million, or 17%, from last year; organic growth of $51 million, or 11% — Operating income of $94.0 million, up

Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025

Two poster presentations will highlight research on the effects of paracentesis and CKD in adults with HRS-AKI1,2- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on terlipressin in patients with hepatorenal syndrome-acute kidney injury (HRS-AKI), at Kidney Week 2025, the annual meeting of the American Society of Nephrology (ASN),

Manulife to Release Third Quarter 2025 Results

C$ unless otherwise stated TSX/NYSE/PSE: MFC SEHK: 945 Manulife Financial Corporation will release its third quarter 2025 financial results after markets close on Wednesday, November 12, 2025, which will be made available at manulife.com/en/investors/results-and-reports. https://mma.prnewswire.com/media/2807480/Manulife_Financial_Corporation_Manulife_to_Release_Third_Quarter.jpg Awebcast and conference call are scheduled for Thursday, November 13, 2025, at 8:00 a.m. (ET) where members of Manulife's executive

Sirona Medical Receives FDA 510(k) Clearance for Advanced Imaging Suite, Expanding Class II Medical Device Functionality and PET-CT Capabilities

Sirona Medical today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona Advanced Imaging Suite, marking a significant regulatory milestone and the company's first Class II medical device designation. https://mma.prnewswire.com/media/1949755/Sirona_Logo.jpg This clearance expands Sirona's diagnostic imaging capabilities to include PET-CT support with quantitative SUV analysis, image fusion, maximum

Merigold and Log10 Announce Partnership to Power Bloom AI — Accelerating Medical Writing with Generative AI

Merigold and Log10 partner to apply Everest's AI technology to the multibillion-dollar imaging clinical trials market, debuting Bloom AI at AMWA 2025 to showcase faster, more accurate documentation and study start-up. Merigold, a leader in imaging trial documentation, has partnered with Log10, creator of Everest, the AI platform for life sciences services, to bring automation

Prime Therapeutics and Sempre Health Expand Innovative Behavior-Based Pricing Model to Advance Patient Affordability

Following strong results with Blue Cross NC, Prime and Sempre expand availability of affordability and adherence solutions to commercial clients nationwide Prime Therapeutics LLC (Prime), a pharmacy solutions organization focused on delivering savings, simplicity, and support, is expanding access to behavior-based medication pricing through a nationwide engagement with Sempre Health (Sempre). This strategic initiative strengthens

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Novavax, Inc. (Nasdaq: NVAX) today announced it will report its third quarter 2025 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, November 6, 2025. Details of the event and replay are as follows: Conference call details:Date: November 6, 2025Time: 8:30 a.m. ETURL to register phone: Register HereDial-in number: (888) 880-3330

Stronger Together: Born Primitive and Black Rifle Coffee Company Unite to Eliminate $25 Million in Medical Debt for American Veterans

In partnership with ForgiveCo, the veteran-owned brands are pledging 100% of profits Veterans Day weekend to eliminate a financial burden for thousands of American heroes This Veterans Day weekend, Born Primitive and Black Rifle Coffee Company, in partnership withForgiveCo, are uniting under one powerful mission: to eliminate up to $25 million in medical debt for

Scroll to Top